If you need more lookups,
subscriptions start at $34 USD/month.
Anna Berglind Location
Denmark
Anna Berglind Work
Vice President Biostatistics, Obesity and Cardiometabolic Health @ (November 2025 - Present)
Vice President Biometrics, Rare Disease and Advanced Therapies @ (November 2024 - November 2025)
Vice President Biostatistics, Rare Disease and Advanced Therapies @ (May 2024 - November 2024)
Executive Director and Head of Immunology Statistics @ (May 2020 - May 2024)
Senior Director and Biometrics Team Leader, Immunology @ (June 2013 - May 2020)
Statistical Science Director, Global Product Statistician @ (August 2011 - May 2013)
Board Member @ (June 2016 - July 2020)
Associate Director @ (October 2005 - July 2011)
Senior statistician @ (January 2002 - January 2005)
Anna Berglind Education
Umeå University
Doctor of Philosophy (Ph.D.) (Mathematical Statistics)
1997-2002
Anna Berglind Skills
Biomarkers
Biostatistics
CRO
CRO Management
Clinical Data Management
Clinical Development
Clinical Research
Clinical Trials
Drug Development
GCP
Good Clinical Practice (GCP)
Infectious Diseases
Management
Neuroscience
Pharmaceutical Industry
Regulatory Submissions
SAS
Science
Statistics
Datawarehouse
Development
SAP
Sourcing
BigData
BI
Data
Business Objects
Webi
Business Intelligence
Datamining
Analytics
Biometrics
Anna Berglind Summary
Anna Berglind, based in Denmark, is currently a Vice President Biostatistics, Obesity and Cardiometabolic Health at Novo Nordisk. Anna Berglind brings experience from previous roles at Novo Nordisk and AstraZeneca. Anna Berglind holds a 1997 - 2002 Doctor of Philosophy (Ph.D.) in Mathematical Statistics @ Umeå University. With a robust skill set that includes Biomarkers, Biostatistics, CRO, CRO Management, Clinical Data Management and more. Anna Berglind has 1 emails on RocketReach.
Looking for a different Anna Berglind?
Find contact details for 700 million professionals.